• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic.

作者信息

Roncati Luca, Roncati Monica

机构信息

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Polyclinic Hospital, Largo del Pozzo 71, 41124, Modena, MO, Italy.

出版信息

J Public Health Policy. 2021 Sep;42(3):518-521. doi: 10.1057/s41271-021-00299-6. Epub 2021 Jul 27.

DOI:10.1057/s41271-021-00299-6
PMID:34316006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8314028/
Abstract
摘要

相似文献

1
Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic.新冠疫情期间的紧急使用授权（EUA）、有条件上市授权（CMA）及预防原则
J Public Health Policy. 2021 Sep;42(3):518-521. doi: 10.1057/s41271-021-00299-6. Epub 2021 Jul 27.
2
The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic.药品的紧急使用授权：在 COVID-19 大流行期间的历史和效用。
Pharmaceut Med. 2021 Jul;35(4):203-213. doi: 10.1007/s40290-021-00397-6. Epub 2021 Aug 28.
3
Use of the conditional marketing authorization pathway for oncology medicines in Europe.欧洲肿瘤药物有条件上市许可途径的使用情况。
Clin Pharmacol Ther. 2015 Nov;98(5):534-41. doi: 10.1002/cpt.174. Epub 2015 Jul 17.
4
Emergency Use Authorization of COVID-19 Vaccine: Implications for Worker Communities.新型冠状病毒肺炎疫苗的紧急使用授权：对工人社区的影响
Workplace Health Saf. 2021 Apr;69(4):152-153. doi: 10.1177/2165079921998657. Epub 2021 Mar 31.
5
BNT162b2 mRNA COVID-19 Vaccine: First Approval.BNT162b2 mRNA COVID-19 疫苗：首次批准。
Drugs. 2021 Mar;81(4):495-501. doi: 10.1007/s40265-021-01480-7.
6
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.新冠疫苗的紧急使用授权——安全性和有效性随访考量
N Engl J Med. 2020 Nov 5;383(19):e107. doi: 10.1056/NEJMp2031373. Epub 2020 Oct 16.
7
Vaccine safety - is the SARS-CoV-2 vaccine any different?疫苗安全性 - SARS-CoV-2 疫苗有何不同？
Hum Vaccin Immunother. 2021 May 4;17(5):1322-1325. doi: 10.1080/21645515.2020.1829414. Epub 2020 Dec 3.
8
Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.在初始候选疫苗获得紧急使用授权或批准上市后评估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗
JAMA. 2021 Jan 19;325(3):221-222. doi: 10.1001/jama.2020.25127.
9
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.新冠肺炎大流行期间的扩大准入计划、同情用药和紧急使用授权。
Drug Discov Today. 2021 Feb;26(2):593-603. doi: 10.1016/j.drudis.2020.11.025. Epub 2020 Nov 27.
10
Emergency authorization of medical products: regulatory challenges from the 2009 H1N1 influenza pandemic in Japan.医疗产品的紧急授权：日本2009年甲型H1N1流感大流行带来的监管挑战
Biosecur Bioterror. 2012 Dec;10(4):372-82. doi: 10.1089/bsp.2012.0017. Epub 2012 Dec 4.

引用本文的文献

1
The Community Pharmacy as a Study Center for the Epidemiological Analysis of the Population Vaccination against SARS-CoV-2: Evaluation of Vaccine Safety and Pharmaceutical Service.社区药房作为针对SARS-CoV-2人群疫苗接种进行流行病学分析的研究中心：疫苗安全性评估与药学服务
Pharmacy (Basel). 2024 Jan 20;12(1):16. doi: 10.3390/pharmacy12010016.
2
Evolution of global scientific collaboration in mRNA vaccine research: Insights from bibliometric and social network analysis (2010~2023).mRNA 疫苗研究的全球科学合作演变：文献计量学和社会网络分析的见解（2010~2023 年）。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2276624. doi: 10.1080/21645515.2023.2276624. Epub 2023 Nov 14.
3
Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteins.新冠疫情的影响：为重组蛋白的首次人体 CMC 数据的基因加速交付提供新方法。
MAbs. 2023 Jan-Dec;15(1):2220150. doi: 10.1080/19420862.2023.2220150.
4
A Three-Case Series of Thrombotic Deaths in Patients over 50 with Comorbidities Temporally after modRNA COVID-19 Vaccination.50岁以上合并症患者在接受mRNA新冠疫苗接种后短期内发生血栓形成死亡的三例系列病例
Pathogens. 2022 Apr 3;11(4):435. doi: 10.3390/pathogens11040435.
5
Cubital Tunnel Syndrome Temporally after COVID-19 Vaccination.新冠疫苗接种后出现的肘管综合征
Trop Med Infect Dis. 2022 Apr 16;7(4):62. doi: 10.3390/tropicalmed7040062.
6
Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate.重组孢子表面的严重急性呼吸综合征冠状病毒2刺突蛋白受体结合域的表达：一种潜在的COVID-19口服疫苗候选物。
Vaccines (Basel). 2021 Dec 21;10(1):2. doi: 10.3390/vaccines10010002.